Last Updated:
Searching
Create account to add to watchlist!

InterPrivate II Acquisition Corp. - IPVA

  • Commons

    $9.75

    -0.02%

    IPVA Vol: 14.5K

  • Warrants

    $0.95

    +7.51%

    IPVA+ Vol: 1.3K

  • Units

    $10.00

    +0.00%

    IPVA= Vol: 205.0

Average: 0
Rating Count: 0
You Rated: Not rated

Please log in to rate.

SPAC Stats

Market Cap: 254.2M
Average Volume: 37.2K
52W Range: $9.65 - $10.71
Weekly %: -0.23%
Monthly %: -0.73%
Inst Owners: nan

Info

Target: Searching
Days Since IPO: 269
Unit composition:
Each unit has an offering price of $10.00 and consists of one share of Class A common stock and one-fourth of one redeemable warrant
Trust Size: 20000000.0M

Management

Officers, Directors and Director Nominees.” Our officers and directors presently have, and any of them in the future may have additional, fiduciary or contractual obligations to other entities and, accordingly, may have conflicts of interest in determining to which entity a particular business opportunity should be presented. Following the completion of this offering and until we consummate our initial business combination, we intend to engage in the business of identifying and combining with one or more businesses. Each of our officers and directors presently has, and any of them in the future may have, additional fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will be required to present a business combination opportunity to such entity. Accordingly, they may have conflicts of interest in determining to which entity a particular business opportunity should be presented. These conflicts may not be resolved in our favor and a potential target business may be presented to another entity prior to its presentation to us. Our amended and restated certificate of incorporation will provide that we renounce our interest in any corporate opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of the company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us to pursue, and to the extent the director or officer is permitted to refer that opportunity to us without violating another legal obligation. In addition, our sponsor and our officers and directors may sponsor or form other special purpose acquisition companies similar to ours or may pursue other business or investment ventures during the period in which we are seeking an initial business combination. As a result, our sponsor, officers and directors could have conflicts of interest in determining whether to present business combination opportunities to us or to any other special purpose acquisition company with which they may become involved. In particular, certain of our officers and directors are actively engaged in IPV III and IPV IV), special purpose acquisition companies that have filed registration statements with the SEC relating to their respective initial public offerings. IPV III and IPV IV, like us, may pursue initial business combination targets in any business or industry and are expected to have similar windows as us in which they may complete their respective initial business combinations. Any such companies, businesses or ventures, including IPV III and IPV IV, may present additional conflicts of interest in pursuing an initial business combination. However, we do not believe that any such potential conflicts would materially affect our ability to complete our initial business combination. For a complete discussion of our executive officers’ and directors’ business affiliations and the potential conflicts of interest that you should be aware of, please see “Management — Officers, Directors and Director Nominees,” “Management — Conflicts of Interest” and “Certain Relationships and Related Party Transactions.” Our executive officers, directors, security holders and their respective affiliates may have competitive pecuniary interests that conflict with our interests. We have not adopted a policy that expressly prohibits our directors, executive officers, security holders or affiliates from having a direct or indirect pecuniary or financial interest in any investment to be acquired or disposed of by us or in any transaction to which we are a party or have an interest. In fact, we may enter into a business combination with a target business that is affiliated with our sponsor, our directors or executive officers, although we do not intend 51 Table of Contents to do so. Nor do we have a policy that expressly prohibits any such persons from engaging for their own account in business activities of the types conducted by us. Accordingly, such persons or entities may have a conflict between their interests and ours. The personal and financial interests of our directors and officers may influence their motivation in timely identifying and selecting a target business and completing a business combination. Consequently, our directors’ and officers’ discretion in identifying and selecting a suitable target business may result in a conflict of interest when determining whether the terms, conditions and timing of a particular business combination are appropriate and in our stockholders’ best interest. If this were the case, it would be a breach of their fiduciary duties to us as a matter of Delaware law and we or our stockholders might have a claim against such individuals for infringing on our stockholders’ rights. However, we might not ultimately be successful in any claim we may make against them for such reason. We may not have sufficient funds to satisfy indemnification claims of our directors and executive officers. We have agreed to indemnify our officers and directors to the fullest extent permitted by law. However, our officers and directors have agreed to waive any right, title, interest or claim of any kind in or to any monies in the trust account and to not seek recourse against the trust account for any reason whatsoever. Accordingly, any indemnification provided will be able to be satisfied by us only if (i) we have sufficient funds outside of the trust account or (ii) we consummate an initial business combination. Our obligation to indemnify our officers and directors may discourage stockholders from bringing a lawsuit against our officers or directors for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against our officers and directors, even though such an action, if successful, might otherwise benefit us and our stockholders. Furthermore, a stockholder’s investment may be adversely affected to the extent we pay the costs of settlement and damage awards against our officers and directors pursuant to these indemnification provisions. Certain agreements related to this offering may be amended without stockholder approval. Each of the agreements related to this offering to which we are a party, other than the warrant agreement and the investment management trust agreement, may be amended without stockholder approval. Such agreements are: the underwriting agreement; the letter agreement among us and our initial stockholders, officers and directors; the registration rights agreement among us and our initial stockholders; the private placement warrants purchase agreement between us and our sponsor; and the administrative services agreement among us, our sponsor and an affiliate of our sponsor. These agreements contain various provisions that our public stockholders might deem to be material. For example, our letter agreement and the underwriting agreement contain certain lock-up provisions with respect to the founder shares, private placement warrants and other securities held by our initial stockholders, officers and directors. Amendments to such agreements would require the consent of the applicable parties thereto and would need to be approved by our board of directors, which may do so for a variety of reasons, including to facilitate our initial business combination. While we do not expect our board of directors to approve any amendment to any of these agreements prior to our initial business combination, it may be possible that our board of directors, in exercising its business judgment and subject to its fiduciary duties, chooses to approve one or more amendments to any such agreement. Any amendment entered into in connection with the consummation of our initial business combination will be disclosed in our proxy materials or tender offer documents, as applicable, related to such initial business combination, and any other material amendment to any of our material agreements will be disclosed in a filing with the SEC. Any such amendments would not require approval from our stockholders, may result in the completion of our initial business combination that may not otherwise have been possible, and may have an adverse effect on the value of an investment in our securities. For example, amendments to the lock-up provision discussed above may result in our initial stockholders selling their securities earlier than they would otherwise be permitted, which may have an adverse effect on the price of our securities. 52 Table of Contents RISKS RELATING TO OUR SECURITIES You will not have any rights or interests in funds from the trust account, except under certain limited circumstances. Therefore, to liquidate your investment, you may be forced to sell your public shares or warrants, potentially at a loss. Our public stockholders will be entitled to receive funds from the trust account only upon the earlier to occur of: (i) our completion of an initial business combination, and then only in connection with those shares of Class A common stock that such stockholder properly elected to redeem, subject to the limitations described herein, (ii) the redemption of any public shares properly tendered in connection with a stockholder vote to amend our amended and restated certificate of incorporation to modify the substance or timing of our obligation to allow redemption in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of this offering or with respect to any other material provisions relating to stockholders’ rights or pre-initial business combination activity, and (iii) the redemption of our public shares if we are unable to complete an initial business combination within 24 months from the closing of this offering, subject to applicable law and as further described herein. In addition, if our plan to redeem our public shares if we are unable to complete an initial business combination within 24 months from the closing of this offering is not completed for any reason, compliance with Delaware law may require that we submit a plan of dissolution to our then-existing stockholders for approval prior to the distribution of the proceeds held in our trust account. In that case, public stockholders may be forced to wait beyond 24 months from the closing of this offering before they receive funds from our trust account. In no other circumstances will a public stockholder have any right or interest of any kind in the trust account. Holders of warrants will not have any right to the proceeds held in the trust account with respect to the warrants. Accordingly, to liquidate your investment, you may be forced to sell your public shares or warrants, potentially at a loss. The NYSE may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions. We intend to apply to have our units listed on the NYSE on or promptly after the date of this prospectus and our Class A common stock and warrants listed on or promptly after their date of separation. We cannot guarantee that our securities will be approved for listing on the NYSE. Although after giving effect to this offering we expect to meet, on a pro forma basis, the minimum initial listing standards set forth in the NYSE listing standards, we cannot assure you that our securities will be, or will continue to be, listed on the NYSE in the future or prior to our initial business combination. In order to continue listing our securities on the NYSE prior to our initial business combination, we must maintain certain financial, distribution and share price levels. Generally, we must maintain a minimum average global market capitalization and a minimum number of holders of our securities. Additionally, in connection with our initial business combination, we will be required to demonstrate compliance with the NYSE’s initial listing requirements, which are more rigorous than the NYSE’s continued listing requirements, in order to continue to maintain the listing of our securities on the NYSE. For instance, our share price would generally be required to be at least $4.00 per share, our global market capitalization would be required to be at least $150 million, the aggregate market value of our publicly-held shares would be required to be at least $40 million and we would be required to have a minimum of 400 round lot holders and 1,100,000 publicly held shares. If the NYSE delists our securities from trading on its exchange and we are not able to list our securities on another national securities exchange, we expect our securities could be quoted on an over-the-counter market. If this were to occur, we could face significant material adverse consequences, including: • a limited availability of market quotations for our securities; • reduced liquidity for our securities; • a determination that our Class A common stock is a “penny stock” which will require brokers trading in our Class A common stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; • a limited amount of news and analyst coverage; and • a decreased ability to issue additional securities or obtain additional financing in the future. 53 Table of Contents The National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to as “covered securities.” Because we expect that our units and eventually our Class A common stock and warrants will be listed on the NYSE, our units, Class A common stock and warrants will qualify as covered securities under the statute. Although the states are preempted from regulating the sale of our securities, the federal statute does allow the states to investigate companies if there is a suspicion of fraud, and, if there is a finding of fraudulent activity, then the states can regulate or bar the sale of covered securities in a particular case. While we are not aware of a state having used these powers to prohibit or restrict the sale of securities issued by blank check companies, other than the State of Idaho, certain state securities regulators view blank check companies unfavorably and might use these powers, or threaten to use these powers, to hinder the sale of securities of blank check companies in their states. Further, if we were no longer listed on the NYSE, our securities would not qualify as covered securities under the statute and we would be subject to regulation in each state in which we offer our securities. Our initial stockholders paid an aggregate of $25,000 to cover certain of our offering costs in exchange for 5,750,000 founder shares, or approximately $0.004 per founder share and, accordingly, you will experience immediate and substantial dilution from the purchase of our shares of Class A common stock. The difference between the public offering price per share (allocating all of the unit purchase price to the share of Class A common stock and none to the warrant included in the unit) and the pro forma net tangible book value per share of our Class A common stock after this offering constitutes the dilution to you and the other investors in this offering. Our initial stockholders acquired the founder shares at a nominal price, significantly contributing to this dilution. Upon closing of this offering, and assuming no value is ascribed to the warrants included in the units, you and the other public stockholders will incur an immediate and substantial dilution of approximately 91.1% or $9.11 per share, assuming no exercise of the underwriters’ over-allotment option), the difference between the pro forma net tangible book value per share after this offering of $0.89 and the initial offering price of $10.00 per unit. This dilution would increase to the extent that the anti-dilution provisions of the founder shares result in the issuance of shares of Class A common stock on a greater than one-to-one basis upon conversion of the founder shares at the time of our initial business combination and would become exacerbated to the extent that public stockholders seek redemptions from the trust for their public shares. In addition, because of the anti-dilution protection in the founder shares, any equity or equity-linked securities issued in connection with our initial business combination would be disproportionately dilutive to our Class A common stock. The determination of the offering price of our units, the size of this offering and terms of the units is more arbitrary than the pricing of securities and size of an offering of an operating company in a particular industry. You may have less assurance, therefore, that the offering price of our units properly reflects the value of such units than you would have in a typical offering of an operating company. Prior to this offering there has been no public market for any of our securities. The public offering price of the units and the terms of the warrants were negotiated between us and the underwriters. In determining the size of this offering, management held customary organizational meetings with the representative of the underwriters, both prior to our inception and thereafter, with respect to the state of capital markets, generally, and the amount the underwriters believed they reasonably could raise on our behalf. Factors considered in determining the size of this offering, prices and terms of the units, including the Class A common stock and warrants underlying the units, include: • the history and prospects of companies whose principal business is the acquisition of other companies; • prior offerings of those companies; • our prospects for acquiring an operating business at attractive values; • a review of debt to equity ratios in leveraged transactions; • our capital structure; • an assessment of our management and their experience in identifying operating companies; • general conditions of the securities markets at the time of this offering; and • other factors as were deemed relevant. 54 Table of Contents Although these factors were considered, the determination of our offering size, price and terms of the units is more arbitrary than the pricing of securities of an operating company in a particular industry since we have no historical operations or financial results. There is currently no market for our securities and a market for our securities may not develop, which would adversely affect the liquidity and price of our securities. There is currently no market for our securities. Stockholders therefore have no access to information about prior market history on which to base their investment decision. Following this offering, the price of our securities may vary significantly due to one or more potential business combinations and general market or economic conditions, including as a result of the COVID-19 pandemic. Furthermore, an active trading market for our securities may never develop or, if developed, it may not be sustained. You may be unable to sell your securities unless a market can be established and sustained. Provisions in our amended and restated certificate of incorporation and Delaware law may inhibit a takeover of us, which could limit the price investors might be willing to pay in the future for our shares of Class A common stock and could entrench management. Our amended and restated certificate of incorporation contains provisions that may discourage unsolicited takeover proposals that stockholders may consider t

Holder Stats

1 0
% of Shares Held by All Insider NaN
% of Shares Held by Institutions NaN
% of Float Held by Institutions NaN
Number of Institutions Holding Shares NaN

Institutional Holders

Reporting Date Hedge Fund Shares Held Market Value % of Portfolio Quarterly Change in Shares Ownership in Company
2021-11-16 Toroso Investments LLC 10,365 $100,000 0.0% 0 0.032%
2021-11-12 Credit Suisse AG 47,419 $460,000 0.0% 0 0.146%

SEC Filings

Form Type Form Description Filing Date Document Link
4 2021-11-24 https://www.sec.gov/Archives/edgar/data/1839608/000121390021061940/xslF345X03/ownership.xml
3 2021-11-24 https://www.sec.gov/Archives/edgar/data/1839608/000121390021061939/xslF345X02/ownership.xml
8-K CURRENT REPORT 2021-11-24 https://www.sec.gov/Archives/edgar/data/1839608/000121390021061934/ea151282-8k_interpriv2.htm
10-Q QUARTERLY REPORT 2021-11-22 https://www.sec.gov/Archives/edgar/data/1839608/000121390021061156/f10q0921_interprivate2.htm
8-K CURRENT REPORT 2021-11-17 https://www.sec.gov/Archives/edgar/data/1839608/000121390021060305/ea150815-8k_interpriv2.htm
NT 10-Q NOTIFICATION OF LATE FILING 2021-11-16 https://www.sec.gov/Archives/edgar/data/1839608/000121390021059677/ea150500-nt10q_interprivate2.htm
10-Q QUARTERLY REPORT 2021-08-18 https://www.sec.gov/Archives/edgar/data/1839608/000121390021043516/f10q0621_interprivate2.htm
NT 10-Q NOTIFICATION OF LATE FILING 2021-08-17 https://www.sec.gov/Archives/edgar/data/1839608/000121390021043207/ea145980-nt10q_interprivate2.htm
10-Q QUARTERLY REPORT 2021-07-23 https://www.sec.gov/Archives/edgar/data/1839608/000121390021038368/f10q0321_interprivate2acq.htm
8-K CURRENT REPORT 2021-06-01 https://www.sec.gov/Archives/edgar/data/1839608/000121390021030245/ea141861-8k_interpriv2.htm
NT 10-Q NOTIFICATION OF LATE FILING 2021-05-18 https://www.sec.gov/Archives/edgar/data/1839608/000121390021027400/ea141155-nt10q_interprivate2.htm
8-K CURRENT REPORT 2021-04-23 https://www.sec.gov/Archives/edgar/data/1839608/000121390021022672/ea139854-8k_interprivateacq2.htm
SC 13G SC 13G 2021-03-19 https://www.sec.gov/Archives/edgar/data/1839608/000119312521086958/d131155dsc13g.htm
8-K CURRENT REPORT 2021-03-15 https://www.sec.gov/Archives/edgar/data/1839608/000121390021015439/ea137588-8k_interprivate2.htm
8-K CURRENT REPORT 2021-03-09 https://www.sec.gov/Archives/edgar/data/1839608/000121390021014360/ea137247-8k_interprivate2.htm
424B4 PROSPECTUS SUPPLEMENT 2021-03-09 https://www.sec.gov/Archives/edgar/data/1839608/000121390021014130/f424b40321_interprivate2.htm
EFFECT 2021-03-04 https://www.sec.gov/Archives/edgar/data/1839608/999999999521000840/xslEFFECTX01/primary_doc.xml
3 2021-03-04 https://www.sec.gov/Archives/edgar/data/1839608/000121390021013582/xslF345X02/ownership.xml
3 2021-03-04 https://www.sec.gov/Archives/edgar/data/1839608/000121390021013580/xslF345X02/ownership.xml
3 2021-03-04 https://www.sec.gov/Archives/edgar/data/1839608/000121390021013577/xslF345X02/ownership.xml
3 2021-03-04 https://www.sec.gov/Archives/edgar/data/1839608/000121390021013575/xslF345X02/ownership.xml
3 2021-03-04 https://www.sec.gov/Archives/edgar/data/1839608/000121390021013573/xslF345X02/ownership.xml
3 2021-03-04 https://www.sec.gov/Archives/edgar/data/1839608/000121390021013569/xslF345X02/ownership.xml
3 2021-03-04 https://www.sec.gov/Archives/edgar/data/1839608/000121390021013570/xslF345X02/ownership.xml
3 2021-03-04 https://www.sec.gov/Archives/edgar/data/1839608/000121390021013568/xslF345X02/ownership.xml
S-1MEF REGISTRATION STATEMENT 2021-03-04 https://www.sec.gov/Archives/edgar/data/1839608/000121390021013564/ea136953-s1mef_interprivate2.htm
CERT NYSE CERTIFICATION 2021-03-03 https://www.sec.gov/Archives/edgar/data/1839608/000087666121000293/IPVA030321.pdf
8-A12B 8-A12B 2021-03-03 https://www.sec.gov/Archives/edgar/data/1839608/000121390021013056/ea136922-8a12b_interpriv2.htm
CORRESP 2021-03-02 https://www.sec.gov/Archives/edgar/data/1839608/000121390021012982/filename1.htm
CORRESP 2021-03-02 https://www.sec.gov/Archives/edgar/data/1839608/000121390021012981/filename1.htm
S-1/A AMENDMENT NO. 2 TO FORM S-1 2021-03-02 https://www.sec.gov/Archives/edgar/data/1839608/000121390021012709/ea136701-s1a2_interprivate2.htm
CORRESP 2021-02-26 https://www.sec.gov/Archives/edgar/data/1839608/000121390021012109/filename1.htm
S-1/A REGISTRATION STATEMENT 2021-02-26 https://www.sec.gov/Archives/edgar/data/1839608/000121390021012105/fs12021a1_interprivateacq2.htm
UPLOAD 2021-02-25 https://www.sec.gov/Archives/edgar/data/1839608/000000000021002306/filename1.pdf
S-1 REGISTRATION STATEMENT 2021-02-17 https://www.sec.gov/Archives/edgar/data/1839608/000121390021009888/fs12021_interprivateacq2.htm
DRS 2021-01-26 https://www.sec.gov/Archives/edgar/data/1839608/000121390021004190/filename1.htm